Oral squamous cell carcinoma and a clinically negative neck: the value of follow-up.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 21928412.
- Also identified by DOI 10.1002/hed.21642.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In squamous cell carcinoma of the oral cavity (SCCOC), regular follow-up comprises 5 years of prescheduled visits, irrespective of tumor stage/classification and/or treatment. We analyzed our standard treatment and follow-up protocol in patients with a preoperative clinically negative neck (cN0) in SCCOC. This is a retrospective chart analysis. Inventarization of treatment, occult metastatic spread, and follow-up were performed. In all, 197 patients were included. The occult metastatic rate was 24%. Eighty-three percent of recurrent disease presented within 2 years. Fifty-three percent of the patients with recurrent disease visited their physician outside prescheduled control visits. Ultrasound-guided fine-needle aspiration cytology currently is 1 of the most reliable staging techniques in cN0 SCCOC. Regular follow-up could perhaps be limited from 5 to 2 years of prescheduled follow-up visits.
Medical subject headings
- Carcinoma, Squamous Cell
- Mouth Neoplasms
- Neoplasm Recurrence, Local